Se encuentra usted aquí
Agregador de canales de noticias
Tirón insuficiente para recuperar el empleo
Principios básicos para el relanzamiento de la economía
Clips From Today’s Closing Bell
The post Clips From Today’s Closing Bell appeared first on The Reformed Broker.
Planes amigo para cuentas: ING y Abanca ofrecen 50 euros
La familia Porsche: la pasión hecha negocio
Tres valores que batirán al mercado
Welcome to the Equity War
Unknown Unknowns
The post Unknown Unknowns appeared first on The Belle Curve.
Monthly Dividend Stock In Focus: Grupo Aval Acciones y Valores
Published on July 7th, 2021 by Bob Ciura Grupo Aval Acciones y Valores (AVAL) is a financial services company that operates in Colombia and Central America. The stock also offers a dividend yield of nearly 5.0% at the present moment. Grupo Aval also pays a monthly dividend, which allows shareholders to receive income on a […]
The post Monthly Dividend Stock In Focus: Grupo Aval Acciones y Valores appeared first on Sure Dividend.
Lululemon: el lujo llevado al deporte
¿Cuáles son los mejores fondos de inversión de Robeco?
A Emprender solo se aprende emprendiendo. Cualidades del emprendedor.
La Fed eleva el debate sobre la retirada de estímulos
El letargo del bitcoin pone a prueba la paciencia de los inversores
Cinco planes de pensiones mixtos que ganan más del 16% en 2021
Estrellas del pop, PCR y más lujo, así es la gran reapertura de los hoteles de Nueva York
The World’s Tech Giants, Compared to the Size of Economies
It’s no secret that tech giants have exploded in value over the last few years, but the scale can be hard to comprehend.
Through wide-scaling market penetration, smart diversification, and the transformation of products into services, Apple, Microsoft, Amazon, and Google have reached market capitalizations well above $1.5 trillion.
To help us better understand these staggering numbers, a recent study at Mackeeper took the market capitalization of multiple tech giants and compared them with the annual Gross Domestic Product (GDP) of countries.
Editor’s note: While these numbers are interesting to compare, it’s worth noting that they represent different things. Market cap is the total value of shares outstanding in a publicly-traded company and gives an indication of total valuation, and GDP measures the value of all goods and services produced by a country in an entire year.
Companies vs. Countries: Tech Giants
Yes. Visualizations are free to share and post in their original form across the web—even for publishers. Please link back to this page and attribute Visual Capitalist. When do I need a license?
Licenses are required for some commercial uses, translations, or layout modifications. You can even whitelabel our visualizations. Explore your options. Interested in this piece?
Click here to license this visualization.
▼ Use This Visualizationa.bg-showmore-plg-link:hover,a.bg-showmore-plg-link:active,a.bg-showmore-plg-link:focus{color:#0071bb;}
If Apple’s market capitalization was equal to a country’s annual GDP, it might just be in the G7.
At a market cap of more than $2.1 trillion, Apple’s market capitalization is larger than 96% of country GDPs, a list that includes Italy, Brazil, Canada, and Russia.
In fact, only seven countries in the world have a higher GDP than Apple’s market cap.
Further back is Microsoft, which would be the 10th richest country in the world if market cap was equivalent to GDP.
With a market cap of more than $1.9 trillion, Microsoft’s value is larger than the GDP of global powerhouses Brazil, Canada, Russia, and South Korea.
Though all of the tech giants fared well during the COVID-19 pandemic, perhaps none have stood to benefit as much as Amazon.
With online retail and web services both in high demand, Amazon’s market cap has grown to $1.7 trillion, larger than 92% of country GDPs.
Other Companies “Bigger” Than CountriesTech giants aren’t the only companies that would give countries a run for their money.
Country/CompanyNominal GDP (country) or Market Cap (company) United States of America$21,433 B China$14,343 B Japan$5,082 B Germany$3,861 B India$2,869 B United Kingdom$2,829 B France$2,716 B Apple$2,125 B Italy$2,004 B Microsoft$1,942 B Saudi Aramco$1,888 B Brazil$1,840 B Canada$1,736 B Russia$1700 B Amazon$1,688 B Alphabet$1,656 B South Korea$1,647 B Australia$1,397 B Spain$1,393 B Mexico$1,269 B Indonesia$1,119 B Facebook$939 B Netherlands$907 B Saudi Arabia$793 B Turkey$761 B Tencent$736 B Switzerland$703 B Poland$596 B Market cap data as of June 13, 2021
Saudi Arabia’s state-owned corporation Saudi Aramco also makes the list, boasting a market cap more than double the GDP of its home country.
China’s tech giant Tencent also has a market cap that towers over many country GDPs, such as those of Switzerland or Poland.
Until recently, Tencent was also ahead of fellow tech giant Facebook in market cap, but the social network has climbed ahead and almost reached $1 trillion in market capitalization.
Of course, the biggest caveat to consider with these comparisons is the difference between market cap and GDP numbers.
A company’s market cap is a proxy of its net worth in the eyes of public markets and changes constantly, while GDP measures the economic output of a country in a given year.
But companies directly and indirectly affect the economies of countries around the world. With international reach, wealth accumulation, and impact, it’s important to consider just how much wealth and power these companies have.
The post The World’s Tech Giants, Compared to the Size of Economies appeared first on Visual Capitalist.
When Big Data and Plant-Based Medical Treatments Collide
The following content is sponsored by RYAH MedTech
When Big Data and Plant-Based Medical Treatments CollidePlant-based medical treatments are gaining popularity, as consumers become increasingly more privy to their various health benefits.
By 2030, the global botanical and plant-derived drug market is expected to reach $37.8 billion, at a compound annual growth rate (CAGR) of 3.5%.
Yet, while its future looks promising, the industry still some roadblocks to overcome. This graphic by RYAH MedTech looks at the key issues the plant-based medical industry is facing, and how big data can help solve them.
Key Industry RoadblocksPlant-based treatments—such as medical cannabis—have come a long way in recent years. However, inconsistencies in regulation and dosage are making it hard for the industry to reach its full potential.
- Inconsistent regulation
Access to medical cannabis is still not equal across America, but legalization is becoming increasingly more widespread. For instance, Kansas passed a bill earlier this year that will legalize medical cannabis, as soon as the legislation is passed through the Senate. - Inconsistent dosage standards
While consumers have expressed a desire for standardized dosing, there is no current jurisdiction to guide consumption. For example, studies have shown a lack of genetic consistency among different products that claim to use the same strain. - Knowledge gap
Many physicians see the value in plant-based treatments, but some still don’t feel comfortable talking to patients about it. A recent survey found that 50% of Michigan-based healthcare respondents—where medical cannabis has been legal since 2008—didn’t feel comfortable answering patient questions about medical cannabis.
In order to overcome these challenges, the industry needs to fill the knowledge gap and ultimately boost credibility.
For this to happen, plant-based treatments need to become more predictable and standardized. And that’s where big data and analytics can help.
Big Data’s Big Role in the IndustryBig data refers to large datasets that continually grow. These datasets are made up of information that is sourced from things like apps, devices, and online platforms. The need to leverage data in the plant-based medicine industry has resulted in an explosion of innovation.
RYAH MedTech collects massive amounts of patient data through devices such as smart inhalers, pens, and patches. These devices track, synthesize, and analyze patient information, which can help create a more personalized treatment plan tailored to the patient and their specific needs.
In addition to helping boost the patient’s experience, big data also has the potential to fill the knowledge gap within the plant-based medical industry and give physicians the information they need, which could boost its overall credibility.
Data is the AnswerPlant-based medical treatments have vast potential—so much so, that adjacent industries are taking measures to protect their market share.
But the industry needs to become more standardized before it can level up. This is why companies like RYAH MedTech are helping to close the gap in missing data, through a suite of IoT devices and software.
The post When Big Data and Plant-Based Medical Treatments Collide appeared first on Visual Capitalist.
Informe mensual Valentum Junio 2021: Análisis de Farmae y Prosus
Páginas
